Dsip (Delta Sleep-Inducing Peptide)

Overview

DSIP, or Delta Sleep-Inducing Peptide, is a neuropeptide that promotes delta-wave sleep and helps regulate sleep architecture. It may normalize disrupted sleep patterns, lower stress hormones, and has been investigated for insomnia and withdrawal syndromes. Like most peptides, it is typically a research chemical requiring reconstitution, given subcutaneously or nasally, with purity and storage mattering.

Expert Review

The page was reviewed by Dr. Dimitar Marinov, MD, PhD, a nutrition researcher, who noted that DSIP may be useful sleep support but stressed that its long-term safety is still unknown.

What the Research Shows

Most of the evidence comes from animal models, with a smaller amount of human work. Animal studies report that DSIP activates the hypothalamic circuitry behind luteinizing hormone release during sleep, produces strong central pain relief in mice and rats, and stimulates growth hormone release through dopaminergic mechanisms in a dose-dependent way. Review articles describe broad effects on physiology, neurotransmitters, circadian rhythm, hormones, and psychological performance, and frame it as a promising sleep agent with potential uses in insomnia, pain, and withdrawal. On the human side, an observational study found DSIP increased total sleep time and improved sleep efficiency without observed side effects, and a pharmacokinetic reference documents the upper dose tested in humans at 21.4 mcg/kg/day intravenously.

Community Sentiment

Across 144 community reports, sentiment is 52% positive, 30% neutral, and 18% negative. The dominant reported benefit is sleep, with smaller mentions of feeling rested and improved mood. The most cited downsides are early-morning awakening, poor sleep on some nights, occasional nausea, and minor bruising.

Dosage

A typical range is 100-300 mcg before bed. The highest dose tested in published studies is 21.4 mcg/kg/day intravenously. It can be injected subcutaneously or used intranasally, and a commonly reported cycling pattern is up to four weeks on followed by four weeks off.

Effectiveness

DSIP appears most useful for people with disturbed sleep. Benefits tend to accumulate over days to weeks rather than appearing all at once, and response varies widely: some users report dramatic improvement while others notice little.

Availability

It is sold as a research chemical through peptide suppliers, with notable quality variation, so reputable vendors matter. It is less widely available than some other peptides.

Bottom Line

DSIP has a fairly large body of research behind its grade, but the bulk of it is animal work, and the human studies, while present, are limited. The most honest summary is the reviewer's own: it may help with sleep, but no one can vouch for its long-term safety, and the gray-market sourcing adds a purity question on top of that.